CytoDyn to Present at BIO CEO & Investor Conference 2019 on February 11

VANCOUVER, Washington, Feb. 08, 2019 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), CytoDyn, a biotechnology company developing a novel humanized CCR5 monoclonal antibody for multiple therapeutic indications, announces that it will be presenting a company overview at BIO CEO & Investor Conference 2019 on Monday, February 11, at 9:45 a.m. Eastern time (6:45 a.m. Pacific time).  The conference is being held at the Marriott Marquis Hotel in New York City.

The BIO CEO & Investor Conference is an international biotech investor conference focused on established and emerging publicly traded and select private biotech companies.  More information regarding the conference can be found at

The presentation by CytoDyn management is Monday, February 11, at 9:45 a.m. ET.  A live webcast and replay of the presentation at BIO CEO will be available on the Investors section of the Company’s website, The webcast will be available approximately one hour after the webcast presentation ends and will be accessible for 90 days.


Nader Pourhassan, Ph.D.
President & CEO

Cytodyn Logo.jpg

Source: CytoDyn Inc.